Dawn L. Hershman, MD, MS

Combining ovarian suppression and an aromatase inhibitor is an efficacious treatment method for premenopausal women with breast cancer. However, the regimen (which is given long-term) can cause some major adverse events, explained Dawn L. Hershman, MD, MS, professor of medicine and epidemiology at the Columbia University Irving Medical Center.

Dawn L. Hershman, MD, MS, Columbia University Medical Center, discusses preventing chemotherapy-induced peripheral neuropathy (CIPN) in diabetic patients with cancer.